Introduction
The chemistry of heterocycles is an interesting branch in organic chemistry. Quinazolinone derivatives derived from 2-phenyl-4H-3,1-benzoxazin-4-one are important compounds in chemistry and pharmacology. They have drawn much attention due to their broad range of pharmacological properties 1 , which include anticancer 2 , anti-inflammatory 3 , anticonvulsant 4 , and antidiuretic 5 activities. Also quinazolinone such as tryptanthrin have been found to have remarkable antimalarial activity 6 .
1,2,4-Triazoles are associated with diverse pharmacological activities such as analgesic, antiasthmatic, diuretic, antihypersensitive, anticholinergic, antibacterial, antifungal and antiinflammatory activity [7] [8] [9] [10] . These biological data prompted us to synthesize some new quinazol-4-one derivatives containing 1,2,4-triazole ring.
Experimental

General procedures
Melting points were taken in open capillaries and are uncorrected. IR spectra (KBr in cm -1 ) were recorded on Jasco 410 plus FTIR spectrophotometer.
1 H NMR spectra were recorded on a JEOL 300 MHz FT-NMR spectrophotometer using DMSO-d 6 
(4-Amino-phenoxy)-acetic acid ethyl ester (4)
Compound 3 (11.85 g, 0.05 mole) was suspended in 250 mL ethanol and cooled to 10 °C. To this solution, sulphuric acid (3.0 mL, 0.055 mole) was added dropwise with stirring, maintaining the temperature at 10 -15 °C. The reaction mixture was then refluxed for about 2 hours. The excess ethanol was distilled under reduced pressure and then to one-third of the total volume of the solution, 100 mL water was added followed by 20 % of potassium carbonate solution for neutralization. The product was extracted with 3 x 25 mL of dichloromethane. The dichloromethane layer was washed with 3 x 20 mL of water. The compound 4 obtained on distillation of dichloromethane at atmospheric pressure was dried in an oven at 40 °C and recrystallised from benzene, yield 80 %, m.p. 58 °C; IR (KBr) 3382 (NH 2 ), 1740 (C=O ester), 1558, 1509, 1476 (C=C, aromatic).
[4-(4-Oxo-2-phenyl-4H-quinazolin-3-yl)-phenoxy]-acetic acid ethyl ester (5)
A mixture of 2-phenyl-4H-3,1-benzoxazin-4-one (4.46 g, 0.02 mole) and (4-amino-phenoxy) acetic acid ethyl ester 4 (4.29 g, 0.022 mole) in 100 mL pyridine was refluxed for about 12 hours. The reaction mixture was then allowed to cool to room temperature and then added slowly 100 mL of methanol. 
[4-(4-Oxo-2-phenyl-4H-quinazolin-3-yl)-phenoxy]-acetic acid hydrazide (6)
Compound 5 (4.0 g, 0.01 mole) and 2 mL of 99 % hydrazine hydrate in ethanol was refluxed for about 8 hours. The reaction mixture was then allowed to cool to room temperature. The separated white coloured solid was filtered, washed with ethanol and crystallized from 
[4-(4-Oxo-2-phenyl-4H-quinazolin-3-yl)-phenoxy]-acetic acid-N′-(substituted phenyl)-thiosemicarbazides (7a-d)
Compound 6 (0.386g. 0.001 mole) was refluxed with various aromatic phenyl isothiocyanates (0.0011 mole) in isopropyl alcohol (40 mL) with continuous stirring over a period of 16 hours. The crystalline solid obtained on cooling the reaction mixture was filtered, washed with isopropyl alcohol and finally crystallized from ethanol to afford compounds (7a-d). 
[4-(4-Oxo-2-phenyl-4H-quinazolin-3-yl)-phenoxy]-acetic acid-N′-phenyl thiosemicarbazide (7a)
[4-(4-Oxo-2-phenyl-4H-quinazolin-3-yl)-phenoxy]-acetic acid-N′-(4-fluoro-phenyl)-thiosemicarbazide (7b)
[4-(4-Oxo-2-phenyl-4H-quinazolin-3-yl)-phenoxy]-acetic acid-N′-(4-nitro-phenyl)-thiosemicarbazide (7c)
Pale
[4-(4-Oxo-2-phenyl-4H-quinazolin-3-yl)-phenoxy]-acetic acid-N′-(2,4-difluorophenyl)-thiosemicarbazide (7d)
3-[4-(4-Substituted phenyl-5-thioxo-4,5-dihydro-1H-[1,2,4]triazol-3-yl-methoxy)-phenyl]-2-phenyl-3H-quinazolin-4-ones (8a-d)
To the hot reaction mixture of compounds (7a-d, 0.0005 mole) in 50 mL of ethanol was added sodium metal (0.001 mole) pieces and the reaction mixture was refluxed with continuous stirring over a period of 4 hours. The excess ethanol was distilled under atmospheric pressure till 3-4 mL was left behind. The viscous liquid obtained on cooling was poured into 20 mL of cold water, followed by neutralized with 1:1 hydrochloric acid under cold condition. The product obtained was filtered, washed thoroughly with water and crystallised from ethanol to give compounds (8a-d). 
3-[4-(4-Phenyl-5-thioxo-4,5-dihydro-1H-[1,2,4]triazol-3-yl-methoxy)-phenyl]-2-phenyl-3H-quinazolin-4-one (8a)
Colorless
3-{4-[4-(4-Fluoro-phenyl)-5-thioxo-4,5-dihydro-1H-[1,2,4]triazol-3-yl-methoxy]-phenyl}-2-phenyl-3H-quinazolin-4-one (8b)
3-{4-[4-(4-Nitro-phenyl)-5-thioxo-4,5-dihydro-1H-[1,2,4]triazol-3-yl-methoxy]-phenyl}-2-phenyl-3H-quinazolin-4-one (8c)
3-{4-[4-(2,4-Difluoro-phenyl)-5-thioxo-4,5-dihydro-1H-[1,2,4]triazol-3-yl-ethoxy]-phenyl}-2-phenyl-3H-quinazolin-4-one (8d)
Results and Discussion
4-Hydroxy-phenyl acetamide 1 on electrophilic substitution with ethyl chloroacetate gave (4-acetylamino-phenoxy)-acetic acid ethyl ester 2 which on hydrolysis with aqueous hydrochloric acid gave 4-(amino-phenoxy)-acetic acid 3. This on further esterification with sulphuric acid gave 4-(amino-phenoxy)-acetic acid ethyl ester 11 
4.
The 2-phenyl-4H-3,1-benzoxazin-4-one 12,13 which was prepared from 2-amino anthranilic acid and benzoyl chloride at 20 -25 °C in pyridine was allowed to react with 4- 
Biological Activity Antibacterial activity
All the newly synthesized compounds (8a-d) were screened in vitro for their antibacterial activity against Staphylococcus aureus, Escherichia coli and Bacillus subtilis by the ditchplate technique 20 using concentrations of 50 µg/mL. Nutrient agar was employed as culture media and DMF was used as solvent control for antibacterial activity.
Antifungal activity
The compounds (8a-d) synthesized were screened for their antifungal activity against Aspergillus niger, Candida albicans and Cryptococcus neoformans by paper-disc diffusion method 21 at concentrations of 50 µg/mL. Nutrient agar was employed as culture media and DMF was used as solvent control for antifungal activity.
The known compounds, such as ampicillin, amoxicillin, norfloxacin, penicillin and Griseofulvin were used for comparison purpose. The diameter of zone of inhibition was measured in mm. The antibacterial and antifungal screening data are recorded in Table 1 . From the Table 1 , it can be seen that the compounds 8c and 8d showed remarkable activity against Staphylococcus aureus, compounds 8b and 8c showed remarkable activity against Bacillus subtilis. The compounds 8c showed good activity against A.niger and the compounds 8a and 8c showed maximum activity against cryptococcus neoformans.
Antimalarial activity
The effort to find new antimalarial activity is still a high priority given to the increasing malarial emergency due to chloroquine resistant Plasmodium falciparum strains. The chloroquine-resistant Plasmodium falciparum malarial parasite was cultured in vitro and the sensitivity of parasite to the newly synthesized compounds was evaluated using the tritiated Hypoxanthine incorporation assay 16 . The compounds (8a-d) were tested for antimalarial activity and the only compound 3-{4-[4-(4-fluoro-phenyl)-4H-[1,2,4]triazol-3-yl-methoxy]-phenyl}-2-phenyl-3H-quinazolin-4-one 8b was found to be most active against Plasmodium falciparum strains and its 50 % inhibitor concentration (IC50) values were 1.2µM.
